{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:45:09Z","timestamp":1772246709566,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Higher Education","award":["FRGS\/1\/2019\/SKK06\/TAYLOR\/02\/3"],"award-info":[{"award-number":["FRGS\/1\/2019\/SKK06\/TAYLOR\/02\/3"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Radioembolization shows great potential as a treatment for intermediate- and advanced-stage liver cancer. However, the choices of radioembolic agents are currently limited, and hence the treatment is relatively costly compared to other approaches. In this study, a facile preparation method was developed to produce samarium carbonate-polymethacrylate [152Sm2(CO3)3-PMA] microspheres as neutron activatable radioembolic microspheres for hepatic radioembolization. The developed microspheres emits both therapeutic beta and diagnostic gamma radiations for post-procedural imaging. The 152Sm2(CO3)3-PMA microspheres were produced from commercially available PMA microspheres through the in situ formation of 152Sm2(CO3)3 within the pores of the PMA microspheres. Physicochemical characterization, gamma spectrometry and radionuclide retention assay were performed to evaluate the performance and stability of the developed microspheres. The mean diameter of the developed microspheres was determined as 29.30 \u00b1 0.18 \u00b5m. The scanning electron microscopic images show that the spherical and smooth morphology of the microspheres remained after neutron activation. The 153Sm was successful incorporated into the microspheres with no elemental and radionuclide impurities produced after neutron activation, as indicated by the energy dispersive X-ray analysis and gamma spectrometry. Fourier transform infrared spectroscopy confirmed that there was no alteration to the chemical groups of the microspheres after neutron activation. After 18 h of neutron activation, the microspheres produced an activity of 4.40 \u00b1 0.08 GBq.g\u22121. The retention of 153Sm on the microspheres was greatly improved to greater than 98% over 120 h when compared to conventionally radiolabeling method at ~85%. The 153Sm2(CO3)3-PMA microspheres achieved suitable physicochemical properties as theragnostic agent for hepatic radioembolization and demonstrated high radionuclide purity and 153Sm retention efficiency in human blood plasma.<\/jats:p>","DOI":"10.3390\/pharmaceutics15030877","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T03:03:23Z","timestamp":1678331003000},"page":"877","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Facile Preparation of Samarium Carbonate-Polymethacrylate Microspheres as a Neutron-Activatable Radioembolic Agent for Hepatic Radioembolization"],"prefix":"10.3390","volume":"15","author":[{"given":"Yin How","family":"Wong","sequence":"first","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, Taylor\u2019s University, Subang Jaya 47500, Malaysia"},{"name":"Medical Advancement for Better Quality of Life Impact Lab, Taylor\u2019s University, Subang Jaya 47500, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azahari","family":"Kasbollah","sequence":"additional","affiliation":[{"name":"Medical Technology Division, Malaysian Nuclear Agency, Bangi 43000, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basri Johan Jeet","family":"Abdullah","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, Taylor\u2019s University, Subang Jaya 47500, Malaysia"},{"name":"Medical Advancement for Better Quality of Life Impact Lab, Taylor\u2019s University, Subang Jaya 47500, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1572-4143","authenticated-orcid":false,"given":"Chai Hong","family":"Yeong","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, Taylor\u2019s University, Subang Jaya 47500, Malaysia"},{"name":"Medical Advancement for Better Quality of Life Impact Lab, Taylor\u2019s University, Subang Jaya 47500, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.29486","article-title":"Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis","volume":"67","author":"Finn","year":"2018","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/gutjnl-2019-318934","article-title":"Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial","volume":"69","author":"Kudo","year":"2020","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","article-title":"Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial","volume":"6","author":"Edeline","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jlcr.3616","article-title":"Preparation and preliminary in vivo evaluation of 166Ho-labeled microspheres for possible use in radioembolic therapy of liver cancer","volume":"61","author":"Subramanian","year":"2018","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2217\/fon-2017-0443","article-title":"Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma","volume":"14","author":"Filippi","year":"2018","journal-title":"Future Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/1751-2980.13030","article-title":"Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis","volume":"22","author":"Martelletti","year":"2021","journal-title":"J. Dig. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2015.08.048","article-title":"A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging","volume":"217","author":"Satterlee","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1016\/j.biomaterials.2011.07.067","article-title":"Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis","volume":"32","author":"Werner","year":"2011","journal-title":"Biomaterials"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1158\/0008-5472.CAN-03-3845","article-title":"Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.2002.11.076","article-title":"Randomized controlled trial of yttrium-90\u2013labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin\u2019s lymphoma","volume":"20","author":"Witzig","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2967\/jnumed.115.163444","article-title":"A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization","volume":"57","author":"Pasciak","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_15","unstructured":"International Atomic Energy Agency (2019). Research Reactor Database (RRDB), International Atomic Energy Agency."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1021499","DOI":"10.3389\/fbioe.2022.1021499","article-title":"The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization","volume":"10","author":"Tong","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_17","unstructured":"Pillai, M. (2007). Radionuclides for Targeted Therapy, Academia."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/MNM.0b013e32834b3ac8","article-title":"Neutron-activated 153Sm-ion-exchange resin as a tracer for gastrointestinal scintigraphy","volume":"32","author":"Yeong","year":"2011","journal-title":"Nucl. Med. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.apradiso.2011.11.056","article-title":"Production and first use of 153SmCl3-ion exchange resin capsule formulation for assessing gastrointestinal motility","volume":"70","author":"Yeong","year":"2012","journal-title":"Appl. Radiat. Isot."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MNM.0b013e32836141e4","article-title":"Fusion of gamma scintigraphic and magnetic resonance images improves the anatomical delineation of radiotracer for the assessment of gastrointestinal transit","volume":"34","author":"Yeong","year":"2013","journal-title":"Nucl. Med. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tan, H.Y., Wong, Y.H., Kasbollah, A., Md Shah, M.N., Yahya, N., Abdullah, B.J.J., and Yeong, C.H. (2023). Evaluation of Therapeutic Efficacy and Imaging Capabilities of 153Sm2O3-Loaded Polystyrene Microspheres for Intra-Tumoural Radionuclide Therapy of Liver Cancer Using Sprague-Dawley Rat Model. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020536"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2967\/jnumed.119.233965","article-title":"PARP-1\u2013Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma","volume":"61","author":"Lee","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1700996","DOI":"10.1002\/adma.201700996","article-title":"Emerging nanotechnology and advanced materials for cancer radiation therapy","volume":"29","author":"Song","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hashikin, N.A.A., Yeong, C.-H., Abdullah, B.J.J., Ng, K.-H., Chung, L.-Y., Dahalan, R., and Perkins, A.C. (2015). Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138106"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hashikin, N.A.A., Yeong, C.H., Abdullah, B.J.J., Ng, K.H., Chung, L.Y., Dahalan, R., and Perkins, A.C. (2015, January 7\u201312). Samarium-153 Labelled Microparticles for Targeted Radionuclide Therapy Of Liver Tumor. Proceedings of the World Congress on Medical Physics and Biomedical Engineering, Toronto, ON, Canada.","DOI":"10.1007\/978-3-319-19387-8_115"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s002590050440","article-title":"Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: Effects of preparation and neutron activation techniques","volume":"26","author":"Nijsen","year":"1999","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"49","author":"Weber","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_28","first-page":"2139","article-title":"Neutron-activated holmium-166-poly (L-lactic acid) microspheres: A potential agent for the internal radiation therapy of hepatic tumors","volume":"32","author":"Mumper","year":"1991","journal-title":"J. Nucl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.apradiso.2011.05.026","article-title":"Production of glass microspheres comprising 90Y and 177Lu for treating of hepatic tumors with SPECT imaging capabilities","volume":"69","author":"Poorbaygi","year":"2011","journal-title":"Appl. Radiat. Isot."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0360-3016(98)00554-9","article-title":"Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re\/188Re) glass microspheres","volume":"44","author":"Casillas","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Elschot, M., Nijsen, J.F., Dam, A.J., and de Jong, H.W. (2011). Quantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolization. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026174"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13550-017-0341-9","article-title":"Phantom validation of quantitative Y-90 PET\/CT-based dosimetry in liver radioembolization","volume":"7","author":"Pimpinella","year":"2017","journal-title":"EJNMMI Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/01.RVI.0000236744.34720.73","article-title":"Radioembolization with Yttrium-90 Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies: Part 3: Comprehensive Literature Review and Future Direction","volume":"17","author":"Salem","year":"2006","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0969-8043(00)00313-4","article-title":"Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation","volume":"54","author":"Roberts","year":"2001","journal-title":"Appl. Radiat. Isot."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1573405611309010008","article-title":"Radionuclides used in nuclear medicine therapy\u2013From production to dosimetry","volume":"9","author":"Lyra","year":"2013","journal-title":"Curr. Med. Imaging Rev."},{"key":"ref_36","unstructured":"IAEA (2003). Manual for Reactor Produced Radioisotopes, International Atomic Energy Agency."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5493\/wjem.v10.i2.10","article-title":"Neutron-activated biodegradable samarium-153 acetylacetonate-poly-L-lactic acid microspheres for intraarterial radioembolization of hepatic tumors","volume":"10","author":"Wong","year":"2020","journal-title":"World J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s10973-013-3446-z","article-title":"Thermogravimetric analysis of thermal stability of poly(methyl methacrylate) films modified with photoinitiators","volume":"115","author":"Kowalonek","year":"2014","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1081\/DDC-100102195","article-title":"Effects of Thermal Neutron Irradiation on Some Potential Excipients for Colonic Delivery Systems","volume":"25","author":"Ahrabi","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.adro.2016.08.003","article-title":"The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres","volume":"1","author":"Westcott","year":"2016","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_41","unstructured":"Gray, B. (2003). Polymer Based Radionuclide Containing Particulate Material, Google Patents."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2018.06.036","article-title":"Radioactive holmium phosphate microspheres for cancer treatment","volume":"548","author":"Arranja","year":"2018","journal-title":"Int. J. Pharm."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/3\/877\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:50:57Z","timestamp":1760122257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/3\/877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["pharmaceutics15030877"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15030877","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]}}}